THOROLD, ON, July 18 /PRNewswire/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for RNA, DNA and protein purifications, today announced the expansion of its product offerings by launching four new kits geared towards the isolation of RNA and DNA from plants and fungi for research and diagnostic applications. In response to customer demands and emerging needs Norgen developed this new line of kits which are all available in spin-column formats as well as in 96-well plate formats for high throughput applications. The new kits include:
This kit allows for the rapid isolation and purification of genomic DNA from the fungi found on the surface of symptomatic plant samples. A major benefit of this kit is that it does not require the use of physical homogenization steps to isolate the fungal DNA, which are often time consuming and tedious procedures. While a mortar and pestle, a rotor-stator homogenizer or bead mills associated with liquid nitrogen may enhance the DNA extraction yield, they are not suitable methods for use in the analysis of large numbers of samples, and in the area of pathogen diagnosis simple and convenient sample preparation steps are a critical factor in supporting high throughput analysis. The procedure yields sufficient fungal DNA to be used in a number of downstream applications including Real-Time PCR, sequencing, Southern blotting and SNP analysis and the total procedure can be completed less than 60 minutes.
"Our new line of kits to isolate RNA and DNA from plants represents an exciting addition to our high quality novel products. We listened to the demands of our customers and developed kits geared towards current market needs. We are confident that these kits will enable researchers in all areas of plant research, particularly in plant diagnostics" said Dr. Haj-Ahmad, President & CEO of Norgen Biotek.
About Norgen Biotek Corp.
Norgen is an innovative, rapidly growing privately-held fully integrated biotechnology company. We conduct R&D, manufacture and market a variety of commercial sample preparation products derived from our proprietary technology. This technology is used in protein, RNA and DNA purification, isolation, and concentration and clean-up kits. Norgen is actively working on the adoption of this enabling technology into the diagnostic market as well as industrial scale applications. We are seeking suitable channels to market partners. Additional information is available on the company's website: www.norgenbiotek.com
CONTACT: Dr. Yousef Haj-Ahmad, President & CEO, Norgen Biotek Corp.,
Phone: (905) 227-8848, Fax: (905) 227-1061, Email: firstname.lastname@example.org